HAS opinions and decisions
Le guide intitulé « Autorisation d’accès précoce aux médicaments : doctrine d’évaluation de la HAS », ci-joint, est adopté.
eNrtWE1z2jAQvfMrGN9lg0li2jFkWpq0zDRTSsK00wsjpAVEheXog5D++srYSUjHbhIT3XJhjNZ6u5Levl05Pt2ueXMDUjGR9Ly23/KakBBBWbLoeZOrc9T1TvuNeIU3eO+1yG/57dBrEo6V6nmZ1Z8BTpT/8+LrJ7DzQXr9RjMWsxUQ/eg9oxn3v2C1vMBp9k4z3ghGm2vQS0F7Xmr0brQZKy1tFP0bIX+rFBOIg2Jk37qaHu2Px0EG9gxUo0B+xcmiFHQua2ESIyUkeoA1LIS8LYWW0/ZRJ+p2OrU8MDUGJYwkMMJ6OZJiwyjQ8jVgrqCWk/kNvQS54aAzJ6XgwYqsVS1wvMLbMVwPy4P+YK0DvdWohdpRdNzqnkTHYditt1lyb6vKuWMXEaTTThiF3XYnmMuAAmEZxVGCwlbYRq32SRhQEihYI2psTGhlWGGz/4ngHBaAKCCO0RIbDcj+CMn0blDhxD6kQmr7gDAVqc7A7cyFsQeHWKKZNvxuksK5GWFCQKFU2kQimXGL1kAZwWvLLoWoIFn81gOCDeammFXEoGoSa5RFyR1RiqnB49xw5EfC9ZPUpUylHN/6K5XW3Sos7VFokFbB3C0kW8GVtJrK7Z79g58YzoMXRj0pFM9RxJmgDoRJdIXwnY/rbsRA2CzaVp9oPa3W24KLDNTrwf4RSXmdGpkZZ6SuHlvFNKD0ZDysluM3JSuI/hErmEh3UvaDJVTcqNeXyH1KOop+d4K8HJRMw250/C6q31D9suyvqOxnRooUAiudTB2iiMNkLg7VQptQ5VB36fSWSfctsiCYQ0WTjGpquk2hu57eWZK6E4DcUAr6+eyqLre/G5C3l7u/pdCM9u5ZWa/guaiiNpMqA395Xubi9N/rUy5SR91Otx6lZbn2LbVO1fsgsKmSJ6hvE/+tqO4Xpwf6uLt2Oun08s43L02OQp/lHcfzqVVXJZ7qAw+92xTziztUqQ8tDRxwDnlBcSb7w7PXryQPFxtnYY8eKZ87N7tLyE4QXPWXZlaKeFjtsueanEsrDt/mc1bxIbCSl3GQf4TsN+Ig+wDZb/wF/67yhg==
Mprj2v7tppsLLJqJ
